Radcliffe Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Radcliffe Capital Management’s Portfolio TDAC Stock Details TDAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.91M	Sell	271,940 -233,574	-46%	-$2.49M	0.22%	174
2026 Q1	$5.35M	Hold	505,514	–	–	0.4%	87
2025 Q4	$5.3M	Buy	505,514 +1,209	+0.2%	+$12.6K	0.29%	90
2025 Q3	$5.22M	Buy	504,305 +329,001	+188%	+$3.4M	0.32%	62
2025 Q2	$1.8M	Buy	+175,304	New	+$1.78M	0.14%	86

Other funds holding TDAC

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Radcliffe Capital Management's TDAC Position: Q2 2026 in Review

Radcliffe Capital Management reduced its Translational Development Acquisition Corp (TDAC) stake by 46% in Q2 2026, selling an estimated $2.49M and leaving 271,940 shares worth $2.91M. The position accounts for 0.22% of the portfolio, ranked #174.

Radcliffe Capital Management first reported a position in TDAC in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.35M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

Radcliffe Capital Management held 271,940 shares of Translational Development Acquisition Corp worth $2.91M as of Q2 2026.
Radcliffe Capital Management sold 233,574 Translational Development Acquisition Corp shares in Q2 2026, an estimated $2.49M.
Translational Development Acquisition Corp made up 0.22% of Radcliffe Capital Management's portfolio in Q2 2026, its #174 holding.
Radcliffe Capital Management first reported a position in Translational Development Acquisition Corp in Q2 2025 and has held it in 5 quarters since.
Radcliffe Capital Management's Translational Development Acquisition Corp position peaked at $5.35M in Q1 2026.
35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Radcliffe Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.